clinical trials

News

Veru shares plunge despite positive data in obesity trial

Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.

News

Novo Nordisk leaps on new obesity drug data

Shares in Novo Nordisk have risen sharply on new weight-loss data with an injectable formulation of new obesity candidate amycretin.

News

AstraZeneca reveals $570m investment in Canada

AstraZeneca has announced another major investment in Canada, tapping into the country's emergence as a "global hub" for clinical trials.

News

Tris cues up filing for non-opioid pain drug on phase 3 win

Tris Pharma has set its sights on an FDA filing for non-opioid pain drug cebranopadol this year after hitting the mark in an abdominoplasty trial.

R&D

The future of precision psychiatry

The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and

News

High-dose semaglutide ramps up weight loss, says Novo

Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match its main rival in the obesity market.

Veru shares plunge despite positive data in obesity trial

Novo Nordisk leaps on new obesity drug data

AstraZeneca reveals $570m investment in Canada

Tris cues up filing for non-opioid pain drug on phase 3 win

The future of precision psychiatry

High-dose semaglutide ramps up weight loss, says Novo

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

clinical trials

Editor's Picks